The study is to determine the dose response relationship of insulin glargine in type 2
diabetes over a 24-hour period and measuring the differences in glucose production among the
differing doses of glargine.
Hypothesis: Differing doses of insulin glargine over a 24-hour period in type 2 diabetes will
show differing effects on endogenous glucose production, glucose disposal and carbohydrate
and lipid flux.